Latest early-stage breast cancer Stories
EVERGREEN PARK, Ill., Sept.
Clinical experience with the SAVI(TM) breast brachytherapy applicator has been outstanding, according to a scientific poster presented at the 2008 Breast Cancer Symposium, Sept. 5-7, 2008 in Washington, D.C.
WASHINGTON, Sept. 8 /PRNewswire/ -- Early clinical experience with the FDA cleared Axxent(R) Electronic Brachytherapy (eBx) System from Xoft demonstrates that the X-Ray-based, non-isotopic treatment is a viable option for adjuvant therapy for early-stage breast cancer.
REDWOOD CITY, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
FREMONT, Calif., July 25 /PRNewswire/ -- The American Medical Association (AMA) Common Procedural Terminology (CPT) Editorial Panel recently approved a CPT Code for the use of electronic brachytherapy, a novel form of high dose rate radiation therapy for the treatment of early stage breast cancer.
MARIETTA, Ga., April 25 /PRNewswire/ -- WellStar Kennestone Hospital and The Breast Center in Marietta directed by Philip Z. Israel, M.D., announced today that it has completed treatment of the first breast cancer patient with a breakthrough new therapy for early stage breast cancer.
LONDON (Reuters) - A British woman with early-stage breast cancer lost a test case legal bid on Wednesday to force her health authority to pay for the potentially life-saving drug Herceptin, but vowed on Wednesday to continue her battle.
LONDON (Reuters) - A woman with early-stage breast cancer went to the High Court on Monday in an attempt to force her local health authority to pay for the potentially life-saving drug Herceptin.